Presence of HBV S-gene mutants in immunocompromised patients

New Microbiologica

Volumn 35, Issue 1, 2012, Pages 97-98

  Caligiuri, Patrizia ^a   Sticchi, Laura ^a,b   Cerruti, Rita ^b   Icardi, Giancarlo ^a,b   Bruzzone, Bianca ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Escape mutant; HBsAg; Immunocompromised patient

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; LETTER; MUTATION; VIROLOGY;

HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNOCOMPROMISED HOST; MUTATION;

HEPATITIS B VIRUS;

EID: 84856837494     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. CARMAN W.F., ZANETTI A.R., KARAYIANNIS P., WATERS J., MANZILLO G., TANZI E., ET AL. (1990). Vaccine-induced escape mutant of hepatitis B virus. Lancet. 336, 325-329. (Pubitemid 20264145)
2. SHELDON J., SORIANO V. (2008). Hepatitis B virus escape mutants induced by antiviral therapy. J. Antimicrob. Chemoth. 61, 766-768. (Pubitemid 351426057)
3. TORRESI J. (2002). The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus. J. Clin. Virol. 25, 97-106. (Pubitemid 35287234)
4. ZANETTI A.R., TANZI E., MANZILLO G., MAIO G., SBREGLIA C., CAPORASO N., ET AL. (1988). Hepatitis B variant in Europe. Lancet. 2, 1132-1133.
5. HSU CW, YEH CT, CHANG ML, LIAW YF. (2007). Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance. Gastroenterology. 132, 543-550.